Publicou 6 edições por ano
ISSN Imprimir: 0743-4863
ISSN On-line: 2162-660X
Indexed in
Targeted Breast Cancer Nanotherapeutics: Options and Opportunities with Estrogen Receptors
RESUMO
Breast cancer is a multifarious and heterogeneous disease. Identification of molecular alterations of surface/intracellular proteins particularly involved in proliferation and growth of breast cancer cells provides opportunities for the development of new targets for therapy. Several ligands that are routinely employed in targeted delivery to breast cancer cells have been found to be immunogenic. Therefore, endogenous bioligands may serve as a better option, which may be bio-competent and non-immunogenic, including estrogens. Membrane-associated estrogen binding sites are highly over-expressed in cancers of endocrine origin, such as breast. The selective high density of these receptor portals can be utilized for targeted breast cancer therapy. Numerous estrogen−chemotherapeutic agent conjugates have been successfully utilized for targeted drug/DNA delivery. Recently, nanocarrier(s) anchored with estrogens as site-directing ligands for the delivery of bioactive(s) have been exhaustively investigated for breast cancer therapy. This review presents a detail account of how estrogens, anti-estrogens, and their derivatives can be used for site-specific delivery of bioactive(s) to breast cancer cells. The sequential emergence of various estrogen−anticancer drug conjugates is highlighted. Additionally, carrier systems that utilize estrogens/anti-estrogens as ligands for purpose-specific site-selective novel drug delivery platforms have been reviewed and revisited in terms of their realistic clinical applications in breast cancer treatment.
-
Yin Juan-Juan, Zhou Zhi-Wei, Zhou Shu-Feng, Cyclodextrin-based targeting strategies for tumor treatment, Drug Delivery and Translational Research, 3, 4, 2013. Crossref
-
Markoutsa E., Papadia K., Giannou A. D., Spella M., Cagnotto A., Salmona M., Stathopoulos G. T., Antimisiaris S. G., Mono and Dually Decorated Nanoliposomes for Brain Targeting, In Vitro and In Vivo Studies, Pharmaceutical Research, 31, 5, 2014. Crossref
-
Madan Jitender, Gundala Sushma R., Kasetti Yoganjaneyulu, Bharatam Prasad V., Aneja Ritu, Katyal Anju, Jain Upendra K., Enhanced noscapine delivery using estrogen-receptor-targeted nanoparticles for breast cancer therapy, Anti-Cancer Drugs, 25, 6, 2014. Crossref
-
Dissanayake Shama, Denny William A, Gamage Swarna, Sarojini Vijayalekshmi, Recent developments in anticancer drug delivery using cell penetrating and tumor targeting peptides, Journal of Controlled Release, 250, 2017. Crossref
-
Paliwal Rishi, Paliwal Shivani Rai, Kenwat Rameshroo, Kurmi Balak Das, Sahu Mukesh Kumar, Solid lipid nanoparticles: a review on recent perspectives and patents, Expert Opinion on Therapeutic Patents, 30, 3, 2020. Crossref
-
Kunjiappan Selvaraj, Pavadai Parasuraman, Vellaichamy Sivakumar, Ram Kumar Pandian Sureshbabu, Ravishankar Vigneshwaran, Palanisamy Ponnusamy, Govindaraj Saravanan, Srinivasan Gowshiki, Premanand Adhvitha, Sankaranarayanan Murugesan, Theivendren Panneerselvam, Surface receptor‐mediated targeted drug delivery systems for enhanced cancer treatment: A state‐of‐the‐art review, Drug Development Research, 82, 3, 2021. Crossref
-
Chand Pallavi, Kumar Hitesh, Badduri Nihal, Gupta N. Vishal, Bettada Vidya G., Madhunapantula SubbaRao V., Kesharwani Siddharth S., Dey Surajit, Jain Vikas, Design and evaluation of cabazitaxel loaded NLCs against breast cancer cell lines, Colloids and Surfaces B: Biointerfaces, 199, 2021. Crossref
-
Paliwal Rishi, Paliwal Shivani Rai, Controlled Delivery of Chemopreventive Agents, in Advances in Nanochemoprevention, 2020. Crossref
-
Liu Weiwei, Ji Yachao, Sun Yu, Si Lingling, Fu Jianing, Hayashi Toshihiko, Onodera Satoshi, Ikejima Takashi, Estrogen receptors participate in silibinin-caused nuclear translocation of apoptosis-inducing factor in human breast cancer MCF-7 cells, Archives of Biochemistry and Biophysics, 689, 2020. Crossref
-
Yang Huan, Tang Cui, Yin Chunhua, Estrone-modified pH-sensitive glycol chitosan nanoparticles for drug delivery in breast cancer, Acta Biomaterialia, 73, 2018. Crossref
-
Paliwal Rishi, Sulakhiya Kunjbihari, Paliwal Shivani Rai, Singh Vijay, Kenwat Rameshroo, Paramanik Debashish, Role of nanoparticles in neurotoxicity, in Nanomedical Drug Delivery for Neurodegenerative Diseases, 2022. Crossref
-
Gajbe Bharti, Das Kurmi Balak, Kenwat Rameshroo, Paliwal Rishi, Paliwal Shivani Rai, Breast cancer: introduction, in Targeted Nanomedicine for Breast Cancer Therapy, 2022. Crossref
-
Malaiya Akanksha, Singhai Mansha, Paliwal Shivani Rai, Paliwal Rishi, Basics of targeted nanodrug delivery of chemotherapeutics for breast cancer therapy, in Targeted Nanomedicine for Breast Cancer Therapy, 2022. Crossref
-
Kenwat Rameshroo, Paliwal Shivani Rai, Paliwal Rishi, Targeted breast cancer nanotheranostics, in Targeted Nanomedicine for Breast Cancer Therapy, 2022. Crossref
-
Li Weinan, Gong HeXin, Fu Yuhan, Sun Jialin, Wang Yanhong, Novel pH-sensitive nanoparticles based on prodrug strategy to delivery All-Trans Retinoic Acid for breast cancer, Colloids and Surfaces B: Biointerfaces, 219, 2022. Crossref